Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Treasury Shares (2020 - 2026)

Opus Genetics has reported Treasury Shares over the past 5 years, most recently at $128410.0 for Q4 2014.

  • Quarterly Treasury Shares rose 351.99% to $128410.0 in Q4 2014 from the year-ago period, while the trailing twelve-month figure was $128410.0 through Dec 2014, up 351.99% year-over-year, with the annual reading at $128410.0 for FY2014, 351.99% up from the prior year.
  • Treasury Shares was $22.9 million for Q1 2026 at Opus Genetics, roughly flat from $22.9 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $29.4 million in Q1 2025 and troughed at $801700.0 in Q1 2023.
  • The 4-year median for Treasury Shares is $22.9 million (2025), against an average of $16.0 million.
  • Year-over-year, Treasury Shares changed 0.0% in 2011 and then skyrocketed 351.99% in 2014.
  • A 5-year view of Treasury Shares shows it stood at $28410.0 in 2010, then changed by 0.0% to $28410.0 in 2011, then changed by 0.0% to $28410.0 in 2012, then changed by 0.0% to $28410.0 in 2013, then soared by 351.99% to $128410.0 in 2014.
  • Per Business Quant, the three most recent readings for IRD's Treasury Shares are $128410.0 (Q4 2014), $128410.0 (Q3 2014), and $128410.0 (Q2 2014).